AzTrials
AzTrials

Free Tissue FlapsNCT03579277

Radial Forearm Versus the Ulnar Forearm Free Flap

A study testing Radial Forearm Free Flap and Ulnar Forearm Free Flap in people with Free Tissue Flaps, run by Indiana University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study evaluates donor site outcomes in patients receiving radial forearm free flap reconstruction versus ulnar forearm free flap reconstruction. Patients who meet criteria for forearm free flap reconstruction are randomized to receiving either radial forearm free flap or ulnar forearm free flap reconstruction. Read more about this study

Who is it for?
Ages 18 to 120 years
Conditions the study is for
Free Tissue Flaps
What is being tested?
Radial Forearm Free Flap and Ulnar Forearm Free Flap
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
1 Jan 2018to 15 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 120 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with planned forearm free flap reconstruction
  • Patients who are deemed equal surgical candidates for radial forearm free flap and ulnar forearm free flap reconstruction
  • Preoperative Allen's test completed and passed
  • Patients have the capacity to complete the informed consent process

Who cannot join

  • Patients that are not candidates for a forearm flap based on their physiology
  • Clinically evident peripheral neuropathy (e.g., diabetic neuropathy, leprosy)
  • Patients requiring concurrent forearm bone for reconstruction
  • Child, prisoner, or other vulnerable group

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Eskenazi Hospital

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

Official title: Comparison of Functional Outcomes and Morbidity of the Radial Forearm Versus the Ulnar Forearm Free Flap: A Prospective, Randomized Trial

This study evaluates donor site outcomes in patients receiving radial forearm free flap reconstruction versus ulnar forearm free flap reconstruction. Patients who meet criteria for forearm free flap reconstruction are randomized to receiving either radial forearm free flap or ulnar forearm free flap reconstruction.

Read the detailed description

The radial forearm free flap and the ulnar forearm free flap are both well-described procedures used for free tissue transfer in reconstructive surgery. Although forearm free flaps are frequently performed, there is insufficient prospective data looking at the morbidity of the radial compared to ulnar forearm free flaps. The goal of this research study is to characterize the outcomes for each of these two flaps, and to determine if there is surgical equipoise, or if one flap is better than the other.

Being tested
Radial Forearm Free Flap, Ulnar Forearm Free Flap
Keywords
Radial Forearm Free Flap, Ulnar Forearm Free Flap, Free Tissue Transfer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radial Forearm Free FlapProcedure or surgery

    Subjects in this arm will undergo a radial forearm free flap.

  • Ulnar Forearm Free FlapProcedure or surgery

    Subjects in this arm will undergo an ulnar forearm free flap.

Study groups in NCT03579277
Study groupRoleWhat they receive
Radial forearm free flapActive comparatorSubjects in this arm will receive a radial forearm free flap.
Receives: Procedure: Radial Forearm Free Flap
Ulnar forearm free flapActive comparatorSubjects in this arm will receive an ulnar forearm free flap.
Receives: Procedure: Ulnar Forearm Free Flap

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Average Grip Strength (lbs) in the operative hand and non-operative hand

    Subjects' grip strength in their operative hand and non-operative hand, each measured as the maximum amount of force applied by the hand to a Jamar Dynometer in pounds.

    Measured: up to 6 months

  2. Average Key Pinch Strength (lbs) in the operative hand and non-operative hand

    Subjects' pinch strength in their operative hand and non-operative hand, each measured as the maximum amount of force applied with key pinch in pounds.

    Measured: up to 6 months

  3. Average Physician and Patient Rating of Scar Appearance

    Subject's and physician's reported assessment of scar appearance on a Likert scale up to 10.

    Measured: up to 6 months

  4. Aggregated Brief Michigan Hand Questionnaire results (composite score)

    Subjects' reported outcomes of hand function, as measured by the brief Michigan Hand Questionnaire survey results, on a scale up to 100.

    Measured: up to 6 months

  5. Average Static Two Point Discrimination (mm)

    Subjects' static two point discrimination threshold in their finger pads, palm, and dorsum of the hand, in the operative and non-operative extremity, each measured in millimeters.

    Measured: up to 6 months

Secondary outcomes (12)
  1. Number of patients with complete flap loss

    Number of patients with complete flap loss as assessed by chart review.

    Measured: up to 6 months

  2. Number of patients with partial flap loss

    Number of patients with partial flap loss as assessed by chart review.

    Measured: up to 6 months

  3. Number of patients reporting cold intolerance

    Number of patients reporting cold intolerance in the operative and non-operative extremity as assessed by patient's response to questioning them about feeling cold intolerance.

    Measured: up to 6 months

  4. Number of patients reporting neuropathy

    Number of patients reporting cold intolerance as assessed by patient's response to questioning them about feeling neuropathy

    Measured: up to 6 months

  5. Number of patients with postoperative hematoma at donor site

    Number of patients with postoperative hematoma at donor site, as assessed by chart review.

    Measured: up to 6 months

  6. Number of patients with postoperative cellulitis at donor site

    Number of patients with postoperative cellulitis at donor site as assessed by chart review.

    Measured: up to 6 months

  7. Number of patients with postoperative hematoma at recipient site

    Number of patient with postoperative hematoma at recipient site, as assessed by chart review

    Measured: up to 6 months

  8. Number of patient with postoperative infection at recipient site

    Number of patient with postoperative infection at recipient site, as assessed by chart review.

    Measured: up to 6 months

  9. Number of patients experiencing mortality

    Number of patients experiencing mortality, as assessed by chart review.

    Measured: up to 6 months

  10. Number of patients with donor site dehiscence

    Number of patients with donor site dehiscence, as assessed by chart review

    Measured: up to 6 months

  11. Number of patients with partial skin graft non-take

    Number of patients with partial skin graft non-take, as assessed by chart review

    Measured: up to 6 months

  12. Number of patients with complete skin graft non-take

    Number of patients with complete skin graft non-take, as assessed by chart review

    Measured: up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2018
  2. Study start1 Jan 2018
  3. Primary completion15 Jul 2023
  4. Study completion15 Aug 2023

Why it stopped: inadequate enrollment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Subjects are assigned to one of two treatment arms
Masking
Single blind
Who is masked
Investigator
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03579277
Sponsor's protocol ID
1712593520
Status last verified
Aug 2023
First submitted
24 Jan 2018
Last updated
30 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Radial Forearm Free Flap and Ulnar Forearm Free Flap in people with Free Tissue Flaps, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 30 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: inadequate enrollment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Average Grip Strength (lbs) in the operative hand and non-operative hand (time frame: up to 6 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in